AccessPak for HIV PEP Expanded with Kaletra and Bevacizumab Intravenous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Bevacizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: Bevacizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Bevacizumab-awwb
- AccessPak for HIV PEP Expanded with Kaletra-Bevacizumab-awwb Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Bevespi Aerosphere
- AccessPak for HIV PEP Expanded with Kaletra-Bevyxxa
- AccessPak for HIV PEP Expanded with Kaletra-Bexarotene
- AccessPak for HIV PEP Expanded with Kaletra-Bexarotene (Systemic)
- Bevacizumab Intravenous-AccessPak for HIV PEP Expanded with Viracept
- Bevacizumab Intravenous-Accolate
- Bevacizumab Intravenous-Accretropin
- Bevacizumab Intravenous-Accucaine
- Bevacizumab Intravenous-AccuHist Drops
- Bevacizumab Intravenous-AccuHist PDX Drops